SANDOZ GLIMEPIRIDE
SANDOZ GLIMEPIRIDE
Approved
DIN Number
02269619
Drug Class
Human
Market Date
Aug 4, 2005
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02269619
AIG Number0146247003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB12 GLIMEPIRIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLIMEPIRIDEActive
Strength: 4 MG
Monograph: GLIMEPIRIDE